Christina Rowlands

Christina Rowlands has a diverse work experience in the field of healthcare and consulting. Christina is currently working at Envision Pharma Group as a Scientific Director, specializing in Value and Access. Prior to their current role, they took a sabbatical from 2021 to 2022. Before that, they worked at PRMA Consulting Ltd as a Consultant and Senior Analyst from 2017 to 2021. Christina also has experience as a Project Executive at iS health group from 2016 to 2017, and as a Research Associate at Accession Healthcare Consulting Ltd from 2014 to 2016. Christina pursued their PhD at Imperial College London from 2010 to 2014 and interned at Cancer Research UK in 2009.

Christina Rowlands completed their education from 2005 to 2007 at Kendrick School in Reading, during which time no specific degree or field of study were mentioned. Christina then went on to pursue a Bachelor of Science (BSc) in Biomedical Sciences from Royal Holloway, University of London from 2007 to 2010. Finally, they obtained a Doctor of Philosophy (PhD) in Cardiovascular Science from Imperial College London, where they studied from 2010 to 2014.